NCT00955500View on ClinicalTrials.gov

Effects of Proteins in Patients With Cirrhosis and Prior Hepatic Encephalopathy

PHASE4CompletedINTERVENTIONAL
Enrollment

116

Participants

Timeline

Start Date

January 31, 2003

Primary Completion Date

January 31, 2008

Study Completion Date

January 31, 2009

Conditions
Hepatic Encephalopathy
Interventions
DIETARY_SUPPLEMENT

Branched-chain amino acids

30 grams of oral branched-chain amino acids (leucine: 13.5 grams, isoleucine: 9 grams, valine: 7.5 grams) daily

DIETARY_SUPPLEMENT

Maltodextrin

30 grams of oral maltodextrin daily

Trial Locations (3)

08208

Corporació Sanitària Parc Taulí, Sabadell

08003

Hospital del Mar, Barcelona

08025

Hospital de Sant Pau, Barcelona

All Listed Sponsors
lead

Hospital Universitari Vall d'Hebron Research Institute

OTHER

NCT00955500 - Effects of Proteins in Patients With Cirrhosis and Prior Hepatic Encephalopathy | Biotech Hunter | Biotech Hunter